pharmacal

  1. T

    Boca Pharmacal Receives FDA Approval On Hydrocodone Bitartrate And Acetaminophen Oral

    Boca Pharmacal, Inc., announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5mL, the generic version of Hycet® Oral Solution distributed by FSC Laboratories, Inc...
  2. T

    Hi-Tech Pharmacal's ECR Subsidiary To Launch A New Dermatitis Treatment

    Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that it received clearance from the FDA to market Tropazone™ lotion, a prescription dermatological product which will be promoted by Hi-Tech's branded marketing subsidiary, ECR Pharmaceuticals Co., Inc. The product is indicated for the...
Back
Top